Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Partnership for Research on Ebola Virus (PREVAIL) Prevail III: Ebola Natural History Study

NCT02431923 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT02431923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02431923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Partnership for Research on Ebola Virus (PREVAIL) Prevail III: Ebola Natural History Study
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Observational
Overall status
Completed
Start date
December 2, 2017
Completion date
April 30, 2021
Enrollment
4,043 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ebola virus disease